{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:08:01Z","timestamp":1785305281677,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["CNPq; Brazil; 303396\/2014-8"],"award-info":[{"award-number":["CNPq; Brazil; 303396\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijantimicag.2018.03.017","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T11:21:27Z","timestamp":1522063287000},"page":"272-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil"],"prefix":"10.1016","volume":"52","author":[{"given":"Raimunda S\u00e2mia Nogueira","family":"Brilhante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glaucia Morgana de Melo","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucilene Queiroz da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Souza Collares Maia","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana de Aguiar","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 J\u00falio Costa","family":"Sidrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos F\u00e1bio Gadelha","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0001","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s40475-015-0044-0","article-title":"Histoplasmosis infections worldwide: thinking outside of the Ohio River valley","volume":"2","author":"Bahr","year":"2015","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4269\/ajtmh.16-0009","article-title":"High mortality and coinfection in a prospective cohort of human immunodeficiency virus\/acquired immune deficiency syndrome patients with histoplasmosis in Guatemala","volume":"97","author":"Samayoa","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0003","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.trstmh.2012.05.003","article-title":"Histoplasmosis in HIV-positive patients in Cear\u00e1, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates","volume":"106","author":"Brilhante","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0004","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4269\/ajtmh.2006.74.600","article-title":"Risk factors for death in acquired immunodeficiency syndrome-associated disseminated histoplasmosis","volume":"74","author":"de Francesco Daher","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/21505594.2016.1235653","article-title":"Antifungal therapeutics for dimorphic fungal pathogens","volume":"8","author":"Goughenour","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0006","series-title":"M38-A3: reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard \u2014 third edition","year":"2017"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0007","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/AAC.00793-10","article-title":"In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum","volume":"54","author":"Brilhante","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0008","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1128\/AAC.02973-14","article-title":"In vitro antifungal susceptibility profile and correlation of mycelial and yeast forms of molecularly characterized Histoplasma capsulatum strains from India","volume":"58","author":"Kathuria","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0009","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/JCM.02416-16","article-title":"Establishment and use of epidemiological cutoff values for molds and yeasts by use of the Clinical and Laboratory Standards Institute M57 Standard","volume":"55","author":"Lockhart","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0010","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/AAC.02615-13","article-title":"Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole","volume":"58","author":"Espinel-Ingroff","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.riam.2016.04.001","article-title":"The role of epidemiological cutoff values (ECVs\/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds","volume":"33","author":"Espinel-Ingroff","year":"2016","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0012","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/jac\/dkl133","article-title":"Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole","volume":"57","author":"Wheat","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01057-17","article-title":"Multicenter, international study of MIC\/MEC distributions for definition of epidemiological cutoff values for Sporothrix species identified by molecular methods","volume":"61","author":"Espinel-Ingroff","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0014","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1128\/AAC.00686-11","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"55","author":"Espinel-Ingroff","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0015","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.04435-14","article-title":"Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazol resistance among the most clinically relevant species of Mucorales","volume":"59","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0016","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1590\/0074-02760160527","article-title":"Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis","volume":"112","author":"Almeida-Paes","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11046-011-9477-8","article-title":"Feline histoplasmosis in Brazil: clinical and laboratory aspects and a comparative approach of published reports","volume":"173","author":"Brilhante","year":"2012","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0018","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0019","series-title":"Antimicrobial drug resistance","first-page":"987","article-title":"Antifungal drug resistance in histoplasmosis","author":"Wheat","year":"2009"},{"key":"10.1016\/j.ijantimicag.2018.03.017_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/EC.00214-10","article-title":"The yeast-phase virulence requirement for \u03b1-glucan synthase differs among Histoplasma capsulatum chemotypes","volume":"10","author":"Edwards","year":"2011","journal-title":"Eukaryot Cell"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T14:44:17Z","timestamp":1561733057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918300943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0924857918300943"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.03.017","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}